---
schema_version: "secwatch.filing_event.v1"
accession: "0001682852-24-000010"
form_type: "8-K"
ticker: "MRNA"
cik: "0001682852"
company_name: "Moderna, Inc."
filed_at: "2024-02-22T23:59:59+00:00"
generated_at: "2026-06-05T19:37:10.238983+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Moderna Q4 2023 revenue $2.8B, EPS $0.55; FY net loss $4.7B from $3.7B non-cash charges

## Summary
- Q4 revenue $2.8B (-43% YoY); GAAP net income $217M, diluted EPS $0.55.
- FY2023 revenue $6.8B; GAAP net loss $4.7B, diluted EPS ($12.33) from $3.7B non-cash charges (resizing, valuation allowance).
- Reaffirms 2024 product sales ~$4B; expects RSV vaccine (mRNA-1345) regulatory approvals beginning H1 2024 (PDUFA May 12).
- FY2023 COVID vaccine sales $6.7B; U.S. retail market share 48% (vs 37% in 2022).
- 2024 guidance: cost of sales ~35% of product sales; R&D ~$4.5B; SG&A ~$1.3B; year-end cash ~$9B.

## SEC filing metadata
- accession: 0001682852-24-000010
- form_type: 8-K
- ticker: MRNA
- cik: 0001682852
- company_name: Moderna, Inc.
- filed_at: 2024-02-22T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1682852/000168285224000010/0001682852-24-000010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1682852/000168285224000010/mrna-20240222.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001682852-24-000010
- JSON: https://secwatch.observer/filing/0001682852-24-000010.json
- Plain text: https://secwatch.observer/filing/0001682852-24-000010.txt

## Key facts
- Earnings Releases
  Moderna, Inc. reported the fourth quarter and year ended December 31, 2023 results: revenue $2.8 billion, net income $217 million, EPS $0.55. Guidance reaffirmed.
  - Period: the fourth quarter and year ended December 31, 2023
  - Revenue: $2.8 billion
  - Net income: $217 million
  - EPS: $0.55
  - Guidance: reaffirmed
  - Result: reported results
  source text: Posts fourth quarter revenues of $2.8 billion, GAAP net income of $217 million and GAAP diluted EPS of $0.55
  evidence_url: https://www.sec.gov/Archives/edgar/data/1682852/000168285224000010/0001682852-24-000010-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.